Organisation paid for research Program year 2022 Source: CMS Open Payments

Clinedge Llcbtc Network

Neither a doctor nor a teaching hospital

Research payments

$338,320

24 payments

Through program year 2022, Clinedge Llcbtc Network is reported as receiving $338,320 in research payments, across 24 payments.

By program year

2 rows
Year Kind Amount Payments
2022 Research $26,635 7
2021 Research $311,685 17

Breakdown

Who paid Research payments · program years 2021–2022
  1. Biohaven Pharmaceuticals, Inc. $311,685 17 payments
  2. Biohaven Pharmaceutical Holding Company Ltd. $26,635 7 payments
Studies the money was for Research payments · program years 2021–2022
  1. BHV3500-301: Phase 3: Double-Blind Randomized Placebo Controlled Safety and Efficacy Trial of BHV3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine $333,861 22 payments
  2. A Phase 2/3 Open-label Long-Term Safety Trial of BHV3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine $4,459 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record